Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 1,513 | 1,287 | 1,185 | 116 | 0 |
| Cost of Goods | 5,701 | 2,711 | 1,145 | 1,161 | N/A |
| Gross Profit | -4,188 | -1,424 | 40 | -1,045 | N/A |
| Operating Expenses | 18,871 | 15,061 | 16,836 | 15,338 | 17,490 |
| Operating Income | -22,358 | -15,774 | -16,651 | -16,222 | -16,741 |
| Interest Expense | 1,000 | 999 | 993 | 922 | 904 |
| Other Income | 3,828 | 1 | 7 | 16 | 25 |
| Pre-tax Income | -19,530 | -16,772 | -17,637 | -17,128 | -17,620 |
| Net Income Continuous | -19,530 | -16,772 | -17,637 | -17,128 | -17,620 |
| Net Income | $-19,530 | $-16,772 | $-17,637 | $-17,128 | $-17,620 |
| EPS Basic Total Ops | -1,024.20 | 360.00 | -400.00 | -400.00 | -420.00 |
| EPS Basic Continuous Ops | -317.80 | -357.78 | -397.70 | -390.93 | -415.27 |
| EPS Diluted Total Ops | -1,024.20 | 360.00 | -400.00 | -400.00 | -420.00 |
| EPS Diluted Continuous Ops | -317.80 | -357.78 | -397.70 | -390.93 | -415.27 |
| EBITDA(a) | $-21,384 | $-13,960 | $-16,101 | $-15,676 | $-16,020 |